Target selectivity of multispecific antibodies: practical analysis of binding kinetics and avidity

Bispecific antibodies are promising therapeutics for targeting cancer cells with high specificity. The measurement of binding rates and avidity effects in the simultaneous engagement of two antigens by a bispecific antibody is key for understanding and optimizing target selectivity early in the drug development process. The quantitative analysis of individual and cooperative target binding, as well as target selectivity, provides insight on how to engineer the individual affinities of the bispecific antibody arms to achieve minimal off-target binding. In this webinar, you will learn... ...how to analyze affinity and binding of bispecific antibody constructs (measure kinetic parameters) ...how to use target ratio and density control to modulate target engagement (assay setup) ...about the contribution of each binding site and how this translates to read-outs such as surface half-life (analysis) ...how to measure cooperative binding and predict target selectivity (practical implications) 👉 For further information, please visit our website at https://www.dynamic-biosensors.com/​ and reach out to us at [email protected]

Rich n Chip’s Tips and Tricks for Best Quantitation and Kinetics Performance on a BLI system
▶︎

Rich n Chip’s Tips and Tricks for Best Quantitation and Kinetics Performance on a BLI system

How do monoclonal antibodies work? Rituximab, infliximab, adalimumab and others
▶︎

How do monoclonal antibodies work? Rituximab, infliximab, adalimumab and others

SNEV Characterization Series: Nanoparticle Tracking Analysis: Powerful Tool for EV Characterization
▶︎

SNEV Characterization Series: Nanoparticle Tracking Analysis: Powerful Tool for EV Characterization

AI Is Creating A Rare Opportunity For Investors. How Jim Roppel Is Playing It. | Investing With IBD
▶︎

AI Is Creating A Rare Opportunity For Investors. How Jim Roppel Is Playing It. | Investing With IBD

Trump Faces GOP Fury Over Iran Deal; Fox News Blames JD Vance; Iran Gets $300 Billion: A Closer Look
▶︎

Trump Faces GOP Fury Over Iran Deal; Fox News Blames JD Vance; Iran Gets $300 Billion: A Closer Look

Hands-On Power BI Tutorial 📊Beginner to Pro [Full Course] ⚡
▶︎

Hands-On Power BI Tutorial 📊Beginner to Pro [Full Course] ⚡

I Built Retracting Casters that are Actually GOOD
▶︎

I Built Retracting Casters that are Actually GOOD

Argentinien – Österreich Highlights | Gruppe J, FIFA WM 2026 | sportstudio
▶︎

Argentinien – Österreich Highlights | Gruppe J, FIFA WM 2026 | sportstudio

The World's Most Important Machine
▶︎

The World's Most Important Machine

Bioanalytical Chemistry:  Kinetics of Antibody Binding
▶︎

Bioanalytical Chemistry: Kinetics of Antibody Binding

What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service
▶︎

What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service

CNS Infections | Clinical Medicine
▶︎

CNS Infections | Clinical Medicine

We Might Be Wrong About Black Holes
▶︎

We Might Be Wrong About Black Holes

Microsoft Fabric and Power BI - Developer of the Future⚡ [Full Course]
▶︎

Microsoft Fabric and Power BI - Developer of the Future⚡ [Full Course]

Cytometry meets biosensing: Real-time binding kinetics measurements on living cells!
▶︎

Cytometry meets biosensing: Real-time binding kinetics measurements on living cells!

RL for Agents Workshop - Deep Dive on Training Agents with RL and Open Source
▶︎

RL for Agents Workshop - Deep Dive on Training Agents with RL and Open Source

How NOT To Think About Cells
▶︎

How NOT To Think About Cells

Data Analytics for Beginners | Data Analytics Training | Data Analytics Course | Intellipaat
▶︎

Data Analytics for Beginners | Data Analytics Training | Data Analytics Course | Intellipaat

Brian Cox: The quantum roots of reality | Full Interview
▶︎

Brian Cox: The quantum roots of reality | Full Interview

Kinetics of Target Binding: Impact on Drug Activity from Bench to Bedside
▶︎

Kinetics of Target Binding: Impact on Drug Activity from Bench to Bedside